Amarin





Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
AstraZeneca USD 5.23B 272M 2025-09
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09


Amarin - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.